Aim & Scope
Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes. Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines. [1]
Continuations / Journal History
| ( 2001 - 2013 ) | Cancer Immunity | ( 2013 - 9999 ) | Cancer Immunology Research |
2024
Multifunctional bispecific nanovesicles targeting SLAMF7 trigger potent antitumor immunity
M Zhu , Y Wu , T Zhu , ... , X Huang
Cancer Immunology Research , 2024
Impact of scFv on functionality and safety of third generation CD123 CAR T cells
M Fredon , M Poussard , S Biichlé , ... , F Garnache-Ottou
Cancer Immunology Research , 2024
Overexpression of an Engineered SerpinB9 Enhances Allogeneic T-Cell Persistence and Efficacy.
PY Teo , Y Jung , DH Quach , ... , L Low
Cancer Immunology Research , 2024
Editorial Retractions, Expressions of Concern and External Notices
CD28 Costimulatory Domain-Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function.
JC Boucher , G Li , H Kotani , ... , ML Davila
Cancer Immunology Research2021 - VOLUME 9, ISSUE 1 pp 62-74.
25 41
ST Workenhe , JG Pol , BD Lichty , ... , KL Mossman
Cancer Immunology Research2013 - VOLUME 1, ISSUE 5 pp 309-319.
45 45
M Hudecek , D Sommermeyer , PL Kosasih , ... , SR Riddell
Cancer Immunology Research2015 - VOLUME 3, ISSUE 2 pp 125-135.
312 42
Cancer Immunotherapy with T Cells Carrying Bispecific Receptors That Mimic Antibodies.
S Ahn , J Li , C Sun , ... , G Dotti
Cancer Immunology Research2019 - VOLUME 7, ISSUE 5 pp 773-783.
14 31
D Chen , HB Barsoumian , L Yang , ... , JW Welsh
Cancer Immunology Research2020 - VOLUME 8, ISSUE 7 pp 883-894.
48 35
LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization.
J Cao , R Dong , L Jiang , ... , B Yang
Cancer Immunology Research2019 - VOLUME 7, ISSUE 2 pp 292-305.
92 40
PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3.
L Ding , X Chen , X Xu , ... , B Yang
Cancer Immunology Research2019 - VOLUME 7, ISSUE 1 pp 136-149.
66 50